January 17, 2024

Podcast | T-Cell Engagers: The New Cancer Drug?

LabGenius’ CTO, Leonard Wossnig, discusses the intersection of synthetic biology, high-throughput assays, and machine learning in the quest for cancer drugs with Harry Glorikian